Telomere length in patients with osteoarthritis: a systematic review and meta-analysis
- PMID: 34313963
- DOI: 10.1007/s40520-021-01944-6
Telomere length in patients with osteoarthritis: a systematic review and meta-analysis
Abstract
Background: Telomere length (TL) as a biomarker of aging was associated with many age-related diseases. The relationship between TL and osteoarthritis (OA), the most common form of joint diseases, had been investigated in a number of studies, but with the result inconsistent.
Aims: The purpose of this study was to systematically evaluate the relationship between TL and OA.
Methods: Until January 1, 2021, PubMed, Web of Science and Cochrane Library were comprehensively retrieved for relevant literatures. Quality of included literature was assessed using the Newcastle-Ottawa Scale (NOS) assessment scale. The pooled standard mean difference (SMD) with 95% confidence interval (CI) of Leukocytes TL was calculated using random-effect model. Subgroup analysis and meta-regression were used to investigate the potential source of heterogeneity.
Results: Six original studies containing 678 OA patients and 1457 healthy controls were included in this meta-analysis. All six included studies were case-control designed. Pooled results showed that patients with OA had a shorter TL in peripheral blood leukocytes (PBLs) compared with healthy controls, (SMD = - 0.32, 95% CI - 0.57 to - 0.06, Z = - 2.45, P = 0.014). Subgroup and meta-regression analysis showed that sex ratio and body mass index (BMI) were possible sources of heterogeneity. Publication bias was not observed.
Conclusion: The TL of PBLs in patients with OA was shorter than that of healthy controls, suggesting that PBLs TL may be closely associated with the pathogenesis and progression of OA.
Keywords: Aging; Meta-analysis; Osteoarthritis; Telomere length.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2. Cochrane Database Syst Rev. 2018. PMID: 29664187 Free PMC article.
-
Music interventions for improving psychological and physical outcomes in people with cancer.Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD006911. doi: 10.1002/14651858.CD006911.pub4. Cochrane Database Syst Rev. 2021. PMID: 34637527 Free PMC article.
-
WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.Cochrane Database Syst Rev. 2007 Jul 18;2006(1):CD000142. doi: 10.1002/14651858.CD000142.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636601 Free PMC article.
-
Low level laser therapy (Classes I, II and III) for treating osteoarthritis.Cochrane Database Syst Rev. 2004;(3):CD002046. doi: 10.1002/14651858.CD002046.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(1):CD002046. doi: 10.1002/14651858.CD002046.pub3. PMID: 15266461 Updated.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
Cited by
-
Sex-specific differences in telomere length of patients with primary knee osteoarthritis.J Cell Mol Med. 2024 Feb;28(3):e18107. doi: 10.1111/jcmm.18107. Epub 2024 Jan 18. J Cell Mol Med. 2024. PMID: 38235989 Free PMC article.
-
Healthy and Osteoarthritis-Affected Joints Facing the Cellular Crosstalk.Int J Mol Sci. 2023 Feb 18;24(4):4120. doi: 10.3390/ijms24044120. Int J Mol Sci. 2023. PMID: 36835530 Free PMC article. Review.
-
Knee osteoarthritis and adverse health outcomes: an umbrella review of meta-analyses of observational studies.Aging Clin Exp Res. 2023 Feb;35(2):245-252. doi: 10.1007/s40520-022-02289-4. Epub 2022 Nov 4. Aging Clin Exp Res. 2023. PMID: 36331799 Free PMC article.
-
Genetically Predicted Longer Telomere Length May Reduce Risk of Hip Osteoarthritis.Front Genet. 2021 Oct 5;12:718890. doi: 10.3389/fgene.2021.718890. eCollection 2021. Front Genet. 2021. PMID: 34675961 Free PMC article.
References
-
- Dieppe PA, Lohmander LS (2005) Pathogenesis and management of pain in osteoarthritis. Lancet 365:965–973. https://doi.org/10.1016/s0140-6736(05)71086-2 - DOI - PubMed
-
- Kassebaum NJ, Arora M, Barber RM et al (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1603–1658. https://doi.org/10.1016/s0140-6736(16)31460-x - DOI
-
- Murphy L, Schwartz TA, Helmick CG et al (2008) Lifetime risk of symptomatic knee osteoarthritis. Arthr Rheum 59:1207–1213. https://doi.org/10.1002/art.24021 - DOI
-
- Neogi T (2013) The epidemiology and impact of pain in osteoarthritis. Osteoarthr Cartil 21:1145–1153. https://doi.org/10.1016/j.joca.2013.03.018 - DOI
-
- Wang Y, Teichtahl AJ, Cicuttini FM (2016) Osteoarthritis year in review 2015: imaging. Osteoarthr Cartil 24:49–57. https://doi.org/10.1016/j.joca.2015.07.027 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical